Investment
Features
FeesSafety
Academy
More
Pluang+

Compare State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF (SJNK) vs Tilray Brands Inc (TLRY) Price & Performance

State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETFTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF vs Tilray Brands Inc — how do they compare? State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF trades at $24.22 (market cap $4.35B), while Tilray Brands Inc trades at $3.53 (market cap $530.54M). The key difference: State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF is far larger — about 8.2× Tilray Brands Inc's market cap, and Tilray Brands Inc is more actively traded (9,099,075 versus 3,211,044). Which is the better fit depends on your goals — on Pluang, investors hold State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF for 41 Days and Tilray Brands Inc for 31 Days on average.

SJNKTLRY
Market Cap
$4.35B$530.54M
Volume
3,211,0449,099,075
Sector
Fixed IncomeHealth
52-Week High
$25.57$21.00
52-Week Low
$24.13$3.57
Typical Hold Time
41 Days31 Days
Enterprise Value
—$684.46M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF

SJNK (SPDR Bloomberg Short Term High Yield Bond ETF) trades at $24.20, down 0.21% with a bearish technical outlook. The ETF shows strong institutional interest despite recent selling activity by some firms. Dividend distributions remain consistent with recent payments of $0.14-$0.15 per share, providing income appeal in a rising rate environment.

The ETF faces headwinds from technical weakness but maintains income appeal through consistent dividends. Key risks include interest rate sensitivity and institutional selling pressure, while the current yield advantage over Treasuries presents opportunity for income-focused investors in the high-yield bond space.

Tilray Brands Inc

Tilray Brands (TLRY) trades at $3.50, down 5.79% on the day and near its 52-week low. The stock shows bearish technical signals with negative moving averages and recent earnings misses across four consecutive quarters. Despite revenue growth to $821 million in 2025, the company reported a substantial net loss of $2.19 billion, driven by impairment charges and high operating costs. Analyst sentiment remains cautious with 65% hold ratings, though the consensus price target of $65.01 suggests significant potential upside from current levels.

The outlook remains challenging with persistent profitability issues and negative cash flow from operations. Investment opportunity exists if Tilray can achieve projected 2026 revenue growth to $915 million and reduce losses. Key risks include ongoing operational inefficiencies, competitive pressures in the cannabis market, and regulatory uncertainty. The stock's current valuation at 0.44 P/S and 0.33 P/B may attract value investors betting on a turnaround.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SJNK

No sentiment data available yet.

TLRY
54% Buy46% Sell
Avg holding period · 31 Days

Top news

Latest headlines on both assets

About State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF

SJNK invests in U.S. dollar-denominated high-yield corporate bonds with short-term maturities (under five years). It offers higher yields than investment-grade funds but with less interest rate sensitivity than longer-term junk bond ETFs.

Read more on SJNK →

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY →